Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Abgent, Inc

Abgent develops powerful tools to profile posttranslational modifications related to cellular function and disease. Abgent antibodies offer the most extensive coverage targeting protein kinases, phosphatases, methyl and acetyl transferases, ubiquitin and SUMO, glycosylases and other protein modification enzymes. Our mission is to accelerate research and discovery by targeting post-translational modifications that dynamically regulate protein function, and to thereby accelerate understanding of the complex path leading from cell signaling to pathology.
Abgent's innovative products and custom services for the study of proteomic modifications rank us as a selected supplier in Natures 2003 Antibody Technology and 2004 Drug Discovery Features and in The Scientist's 2003 Cell Signaling Feature. Our Strengths
Innovation of exclusive products for a broad range of proteomic and life science applications.
A demonstrated commitment to rapid service at competitive prices, with superior quality. Flexible to unique customer requirements.
Modern facilities and equipment for peptide synthesis, antibody development, protein expression/purification, and assay development.
Project status and data reports are monitored by our exclusive in-house custom service database tracking system.
Skilled biotechnology workforce with interdisciplinary expertise.
Collaborations with leading scientists, institutions, and companies


Contact Details:
6310 Nancy Ridge Dr., Ste. 106
San Diego
California
92121
United States of America
Tel:(858) 622-0099
Fax:(858) 622-0609
Email:info@abgent.com
WWW:

www.abgent.com/




Loading...

BioNews Results for Abgent, Inc:

Guru Stocks at 52-Week Low: Genzyme Corp, Apollo Group Inc, Ralcorp Holdings Inc, Aqua America Inc, MetroPCS C
Guru Focus:  Nov 16 2009 3:51AM Matching: inc
BELLUS Health Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report
PR inside:  Nov 16 2009 4:26AM Matching: inc
BELLUS Health Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report
PR inside:  Nov 16 2009 4:26AM Matching: inc
J.C. Penney, Disney, Genzyme are big movers
Austin American Statesman:  Nov 15 2009 1:20PM Matching: inc
UPDATING and REPLACING -- GeoPharma Announces Fiscal Year 2010 Second Quarter Results Release Date and Confere
Presentation Master:  Nov 15 2009 12:49AM Matching: inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Abgent, Inc news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 852 times since April 2007, the link to the organisation's website has been followed 122 times

Recent Search Terms used to find this page: abgent careers | abgent | abgent | abgent | Abgent | abgent | abgent | Abgent | abgent inc | abgent inc | .

Search for more companies in San Diego

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Abgent, Inc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.